In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies. - Wikidata - awgldk - TriplyDB

In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies.

In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies.

http://www.wikidata.org/entity/Q36259608

about

Delivery of optical contrast agents using Triton-X100, part 1: reversible permeabilization of live cells for intracellular labeling Near-infrared fluorescence imaging of mammalian cells and xenograft tumors with SNAP-tag Antibody-based imaging of HER-2: moving into the clinic.New strategies for fluorescent probe design in medical diagnostic imaging.Neoplasia: the second decade.Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection Toward preparation of antibody-based imaging probe libraries for dual-modality positron emission tomography and fluorescence imaging.Self-assembled gold nanoparticle molecular probes for detecting proteolytic activity in vivo.In vivo stable tumor-specific painting in various colors using dehalogenase-based protein-tag fluorescent ligands.Frontiers in cancer nanomedicine: directing mass transport through biological barriers Exogenous near-infrared fluorophores and their applications in cancer diagnosis: biological and clinical perspectives.Advancing Molecular-Guided Surgery through probe development and testing in a moderate cost evaluation pipeline Activity estimation in radioimmunotherapy using magnetic nanoparticles.Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells Multiplexed imaging in cancer diagnosis: applications and future advances.Clinical implications of near-infrared fluorescence imaging in cancer.In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.Towards detecting the HER-2 receptor and metabolic changes induced by HER-2-targeted therapies using medical imaging.Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Glucosamine-bound near-infrared fluorescent probes with lysosomal specificity for breast tumor imaging.Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization.Protein-based tumor molecular imaging probes.Polychromatic in vivo imaging of multiple targets using visible and near infrared light.Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications Optical imaging for cervical cancer detection: solutions for a continuing global problem.In vivo investigation of breast cancer progression by use of an internal control.Therapy to target renal cell carcinoma using 131I-labeled B7-H3 monoclonal antibody Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer.Delivery of optical contrast agents using Triton-X100, part 2: enhanced mucosal permeation for the detection of cancer biomarkers.Multi-targeted multi-color in vivo optical imaging in a model of disseminated peritoneal ovarian cancer.The War on Cancer rages on.Activatable organic near-infrared fluorescent probes based on a bacteriochlorin platform: synthesis and multicolor in vivo imaging with a single excitation.The promise of nanotechnology for solving clinical problems in breast cancer.Optical and magnetic resonance imaging as complementary modalities in drug discovery.Rapid cancer detection by topically spraying a γ-glutamyltranspeptidase-activated fluorescent probe.Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore.Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition

P2860

Q24649911-126696D5-5717-40A6-9A8D-02E4155F135F Q28730842-3BED4EE4-72AA-418E-AC72-5DC90C508212 Q30423880-9EF37604-FF57-48C5-88BF-02694D547321 Q30472058-7B518221-6543-49AC-800D-969958DB8499 Q30484000-3FF393F4-CE3D-4D76-A0D3-BE826B64BF24 Q33441587-2558E2DA-D54A-436B-92E3-C9F30EC47815 Q33464006-EC10E25F-66A1-4DC5-BC88-322CBBF94128 Q33530511-A8D8081B-C5C1-4242-821E-0A639D4E9974 Q33739542-8F592002-F3A4-47F7-A719-9D48CF5EB8B9 Q33746335-E58E4E25-8E65-411E-92DE-7ABD2413EE17 Q34954961-F18A37E6-DC35-4B3F-87DB-3E01EEBB47B7 Q35518032-2534133F-2131-404B-B8A3-EA9A255F7438 Q35538763-D54BFD3A-C2CF-428B-ADE4-EE958263F493 Q35664300-9FA098D3-174F-45A4-87A1-93BE9B5A4056 Q36143279-9C1F6A7B-1986-4D91-8CB0-BE0B583B019C Q36147746-B6A47323-BB68-43B9-B968-46F874A92F5B Q36245602-6009BBC2-422B-4782-9277-23C7E70DD86C Q36324211-78DBC39B-4343-4F90-A117-7575191487F1 Q36324571-214C2EAA-EF97-45F9-9070-D598CD6FC49C Q36395999-8D153E76-810A-4AC6-A0AB-127126B44EF2 Q36528213-60CD1C36-2B79-4734-92F3-08FB92446D92 Q36564154-2AE45AAE-7734-47D3-9C87-FB561B118CF0 Q36742911-69ECDB3C-FB19-4DFD-8567-87A47F3FD2AB Q36902111-6959E011-9B55-430B-8EF3-935908B4EE03 Q36915308-83D26098-B9D0-4067-AA7F-A94A0CD67784 Q36919600-27F977C8-A88D-4CEB-AFDC-01EBEE282077 Q37078857-9AF47DFA-1B24-4F5F-8C06-A98BF4459EFB Q37109529-F963216C-4F99-47D1-8B62-353CB6587631 Q37269482-C620BE0F-844B-46EB-839D-F36F933A8F1E Q37329697-495A09DA-1990-473D-A32F-960FB5364653 Q37353336-51E9079F-41F6-4200-AF9D-D7322F3E0949 Q37460423-691A267B-3469-4147-82E3-251F4EDA5E3E Q37478602-54E116A0-CAEE-4F68-8CA7-7C8AE4094CED Q37697054-416F83C8-FA2F-4D77-9FBA-52138B4DD537 Q37845311-4A7F2A9D-1276-4F5D-9EC6-B21631F38C2B Q37855905-17830D5E-4084-44B5-BE9F-8379D0AB1F39 Q39437346-F794DB7F-2AE2-440D-8D7B-5229CF1A7B64 Q39606257-834BC71E-E9C1-4BB5-938D-8D0384D120BC Q39744916-6A5FEBA9-5B09-45E3-840C-23955C1048E6 Q39809931-7323EEEE-64E4-40D1-98B8-5D28D1B39962

P2860

In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies.

http://www.wikidata.org/entity/Q36259608

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

In vivo molecular imaging to d ...... labeled monoclonal antibodies.

@ast

In vivo molecular imaging to d ...... labeled monoclonal antibodies.

@en

type

label

In vivo molecular imaging to d ...... labeled monoclonal antibodies.

@ast

In vivo molecular imaging to d ...... labeled monoclonal antibodies.

@en

prefLabel

In vivo molecular imaging to d ...... labeled monoclonal antibodies.

@ast

In vivo molecular imaging to d ...... labeled monoclonal antibodies.

@en

P1433

Q36259608-A051EAB8-7831-4DE9-9D50-DBD6EBFED549

P1476

Q36259608-D854A1AF-37F1-417F-B483-66381D390FF8

P2093

Q36259608-13116D31-6EA0-4A29-B684-589DD4AF730D

Q36259608-1D045ACF-CDDB-4335-B89C-DE8A690BAC43

Q36259608-3A824085-2FCD-4F36-A8BD-9151EFA28EBF

Q36259608-97214272-A7F7-4F33-85CF-0C29F3DAA410

Q36259608-A298C72F-4841-4034-ACAB-9FA205893BE4

Q36259608-F6832B03-C1CC-4478-ACCA-198FC5031BDB

P2860

Q36259608-0889056F-FA5E-4173-AA3C-293E447705CF

Q36259608-09AE5090-D063-4A46-A887-E517BB8A23C6

Q36259608-132B2A98-FAD3-4325-B8C3-22D5AF53FE86

Q36259608-2C6A72DC-1C87-4FA0-96E0-FCAC88F2D1F0

Q36259608-300346A9-44C8-4E8D-BEC4-63426FB816A9

Q36259608-4E136D91-E856-48AC-8D07-19A340067CBB

Q36259608-8496A24B-8A90-4B2B-99B9-1A6EB010C409

Q36259608-8BE24F18-F18B-47E4-9382-9E33E7C039F8

Q36259608-8F03C818-712C-4F3A-A4E4-2FF94104C210

Q36259608-A364A394-4D23-400A-AB4E-269AF1C64F3D

P304

Q36259608-58250C6D-51B2-4287-A642-83A17463F722

P31

Q36259608-3C7B5CB9-163C-4844-AD0C-C56B1685FA19

P356

Q36259608-6726892E-170F-4B29-9CA8-83A1E4896DCE

P433

Q36259608-27A9F0C1-9F18-491B-94E3-E390F975A9A0

P478

Q36259608-EDCCC8A8-F414-4AB7-8629-5449D201A263

P577

Q36259608-9387DFC5-2C1F-4445-AC59-3C30F82953D5

P5875

Q36259608-6755AD62-D5B3-4401-A916-AE14309462F0

P698

Q36259608-56FEC10B-8828-4BCB-9478-8135F75921A5

P921

Q36259608-23E27F59-7AD4-4D18-B4A5-21C913E3AFC1

P932

Q36259608-C26FFE1F-555A-4AB6-9777-DABC4F067D15

P356

P1433

P1476

In vivo molecular imaging to d ...... labeled monoclonal antibodies.

@en

P2093

Gregory Ravizzini

http://www.w3.org/2001/XMLSchema#string

Hisataka Kobayashi

http://www.w3.org/2001/XMLSchema#string

Peter L Choyke

http://www.w3.org/2001/XMLSchema#string

Tristan Barrett

http://www.w3.org/2001/XMLSchema#string

Yoshinori Koyama

http://www.w3.org/2001/XMLSchema#string

Yukihiro Hama

http://www.w3.org/2001/XMLSchema#string

P2860

A fluorescent variant of a protein from the stony coral Montipora facilitates dual-color single-laser fluorescence cross-correlation spectroscopy.

Multispectral imaging in biology and medicine: slices of life.

Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

Near infrared optical applications in molecular imaging. Earlier, more accurate assessment of disease presence, disease course, and efficacy of disease treatment.

The multiple uses of fluorescent proteins to visualize cancer in vivo.

Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment II.

In vivo tumor delivery of the green fluorescent protein gene to report future occurrence of metastasis.

Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma.

Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu.

In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus.

P304

1021-1029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.07787

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5763342

http://www.w3.org/2001/XMLSchema#string

P698

18084609

http://www.w3.org/2001/XMLSchema#string

P921

P932

2134899

http://www.w3.org/2001/XMLSchema#string